BlackRock’s Forte Biosciences FBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$436K Buy
33,695
+26,892
+395% +$348K ﹤0.01% 4410
2025
Q1
$52.8K Hold
6,803
﹤0.01% 4868
2024
Q4
$154K Hold
6,803
﹤0.01% 4620
2024
Q3
$38K Sell
6,803
-191
-3% -$1.07K ﹤0.01% 4813
2024
Q2
$93.9K Hold
6,994
﹤0.01% 4670
2024
Q1
$122K Sell
6,994
-299
-4% -$5.2K ﹤0.01% 4628
2023
Q4
$150K Buy
7,293
+6
+0.1% +$123 ﹤0.01% 4634
2023
Q3
$121K Sell
7,287
-6
-0.1% -$99 ﹤0.01% 4732
2023
Q2
$190K Sell
7,293
-363
-5% -$9.44K ﹤0.01% 4666
2023
Q1
$193K Sell
7,656
-819
-10% -$20.7K ﹤0.01% 4702
2022
Q4
$212K Sell
8,475
-7
-0.1% -$175 ﹤0.01% 4754
2022
Q3
$226K Sell
8,482
-80
-0.9% -$2.13K ﹤0.01% 4857
2022
Q2
$278K Sell
8,562
-23,679
-73% -$769K ﹤0.01% 4856
2022
Q1
$1.18M Sell
32,241
-442
-1% -$16.1K ﹤0.01% 4523
2021
Q4
$1.75M Buy
32,683
+1,814
+6% +$97K ﹤0.01% 4395
2021
Q3
$2.28M Sell
30,869
-136
-0.4% -$10.1K ﹤0.01% 4205
2021
Q2
$26.1M Buy
31,005
+20,538
+196% +$17.3M ﹤0.01% 3089
2021
Q1
$8.97M Buy
10,467
+4,417
+73% +$3.78M ﹤0.01% 3579
2020
Q4
$5.51M Buy
6,050
+1,843
+44% +$1.68M ﹤0.01% 3593
2020
Q3
$5.1M Buy
4,207
+2,229
+113% +$2.7M ﹤0.01% 3476
2020
Q2
$721K Sell
1,978
-2,475
-56% -$902K ﹤0.01% 4047
2020
Q1
$2.04M Sell
4,453
-68
-2% -$31.1K ﹤0.01% 3581
2019
Q4
$903K Buy
4,521
+228
+5% +$45.5K ﹤0.01% 3967
2019
Q3
$1.07M Sell
4,293
-166
-4% -$41.2K ﹤0.01% 3904
2019
Q2
$11.2M Buy
4,459
+30
+0.7% +$75.2K ﹤0.01% 3147
2019
Q1
$18.1M Buy
4,429
+425
+11% +$1.73M ﹤0.01% 2777
2018
Q4
$12.3M Buy
4,004
+235
+6% +$723K ﹤0.01% 2964
2018
Q3
$22M Buy
3,769
+759
+25% +$4.44M ﹤0.01% 2795
2018
Q2
$10.5M Buy
3,010
+166
+6% +$581K ﹤0.01% 3185
2018
Q1
$12.6M Sell
2,844
-7
-0.2% -$31.1K ﹤0.01% 2983
2017
Q4
$11M Buy
2,851
+761
+36% +$2.93M ﹤0.01% 3072
2017
Q3
$9.77M Buy
2,090
+24
+1% +$112K ﹤0.01% 3136
2017
Q2
$9.32M Buy
+2,066
New +$9.32M ﹤0.01% 3172